Shokeikai

Medical Corporation Shokeikai is a Japanese healthcare organization primarily recognized for its specialized clinical research capabilities through Kojin Hospital. The organization operates a dedicated Phase 1 clinical trial unit that partners with global pharmaceutical companies and contract research organizations to conduct early-stage human clinical trials, including first-in-human and bioequivalence studies. With a focus on high-quality data collection and volunteer safety, Shokeikai provides the infrastructure and medical oversight necessary for complex pharmacological evaluations. Their facilities are equipped to handle both healthy volunteer and patient-based studies across various therapeutic areas, ensuring compliance with Good Clinical Practice (GCP) standards. As a key player in the Japanese drug development ecosystem, Shokeikai facilitates the entry of new therapeutics into the Asian market by providing robust pharmacokinetic and pharmacodynamic data.